Taiwanese company Health2Sync is tackling the problem of diabetes in Asia, which accounts for 60% of the world's sufferers. The firm has developed a device that monitors blood sugar levels and sends alerts to smartphone apps when it reaches dangerous levels. Health2Sync said within three months, high-risk users experienced a 22% drop in average blood glucose levels. The company, which recently closed a $6m series B round, aims to expand beyond its main market in Japan into southeast Asia.
Taiwanese company Health2Sync is tackling the problem of diabetes in Asia, which accounts for 60% of the world's sufferers. It has developed a tracking service, combining a Bluetooth dongle and a smartphone app, which allows users to monitor medication, diet and exercise, as well as offering analytics and feedback. Health2Sync said within three months, high-risk users experienced a 22% drop in average blood glucose levels. The company, which recently closed a $6m series B round, aims to expand beyond its main market in Japan into southeast Asia.